Edition:
United Kingdom

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

9.78USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$9.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,272
52-wk High
$10.55
52-wk Low
$5.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.81 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 13.15 13.35 12.80 12.06
Quarter Ending Mar-18 1 13.90 13.90 13.90 --
Year Ending Dec-17 3 65.91 66.14 65.50 59.23
Year Ending Dec-18 3 66.08 70.93 63.60 71.89
Earnings (per share)
Quarter Ending Dec-17 3 -0.81 -0.63 -1.12 -1.00
Quarter Ending Mar-18 1 -0.68 -0.68 -0.68 --
Year Ending Dec-17 3 -2.34 -2.26 -2.49 -2.74
Year Ending Dec-18 3 -3.20 -2.05 -4.31 -2.48

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 13.68 17.11 3.43 25.08
Quarter Ending Jun-17 14.59 16.93 2.34 16.06
Quarter Ending Mar-17 15.16 18.74 3.58 23.62
Quarter Ending Dec-16 13.66 17.36 3.70 27.12
Quarter Ending Sep-16 13.50 16.95 3.45 25.56

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 13.15 13.15 13.15 13.97 12.06
Quarter Ending Mar-18 13.90 13.90 13.90 13.80 --
Year Ending Dec-17 65.91 65.91 65.91 63.31 59.23
Year Ending Dec-18 66.08 66.08 66.08 65.00 71.89

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings